Personalized cell shots tested in battle against deadly brain cancer
Disease control
Ongoing
This study is testing whether a personalized cell-based immunotherapy called IGV-001 can help control glioblastoma, a fast-growing brain cancer, and help patients live longer. The treatment is made from a patient's own tumor cells and is designed to train their immune system to f…
Phase: PHASE2 • Sponsor: Imvax • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC